Kristopher Bedi, DO
Obstetrics/Gynecology · Fresno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 19 years
- Graduated 2007
Offices
3 locations · Saint Agnes Medical Foundation · 161 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bedi’s office to ask if they take your plan before you enroll.
Original Medicare doctor bills
$6,822
Medicare paid this office $6,822 for 34 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 15 | $2,279 | $95 |
| Short return visit (20+ min) | 20 | $1,806 | $69 |
Procedures year by year
| Procedure | 2015 | 2016 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Irrigation of vagina and/or application of drug to treat infection | 72 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
34 Original Medicare patients in 2024. Average age 68 · Women 100% · Also on Medicaid 38% · Health risk score 0.86. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 74% · Diabetes 32%.
The office billed $21,394, Medicare allowed $9,597 and paid $6,822; for 90 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 34 | 90 | 68 | 0.86 | $21,394 | $6,822 |
| 2023 | 41 | 108 | 65 | 1.02 | $33,641 | $10,877 |
| 2022 | 39 | 103 | 67 | 0.99 | $23,119 | $8,422 |
| 2021 | 12 | 29 | 58 | 0.79 | $6,103 | $2,321 |
| 2016 | 37 | 103 | 73 | 0.96 | $23,306 | $4,787 |
| 2015 | 192 | 602 | 76 | 1.27 | $95,489 | $16,895 |
| 2014 | 628 | 3,279 | 77 | 1.07 | $444,781 | $125,023 |
| 2013 | 556 | 2,345 | 76 | 1.06 | $423,257 | $127,107 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 22 | $3,147 | $93 |
| Short return visit (20+ min) | 13 | $1,135 | $67 |
| New patient visit (45+ min) | 11 | $942 | $86 |
2022: 4 services
| Return visit (30+ min) | 18 | $3,181 | $99 |
| New patient visit (45+ min) | 13 | $1,607 | $124 |
| Short return visit (20+ min) | 15 | $902 | $53 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $484 | $40 |
2016: 1 service
| Short return visit (20+ min) | 26 | $1,975 | $47 |
2015: 4 services
| Short return visit (20+ min) | 129 | $5,858 | $37 |
| Return visit (30+ min) | 47 | $3,089 | $61 |
| Irrigation of vagina and/or application of drug to treat infection | 71 | $1,457 | $20 |
| Automated urinalysis test | 27 | $93 | $3 |
2014: 12 services
| Short return visit (20+ min) | 480 | $46,695 | $53 |
| Return visit (30+ min) | 205 | $19,072 | $77 |
| Irrigation of vagina and/or application of drug to treat infection | 279 | $17,432 | $34 |
| New patient visit (45+ min) | 73 | $8,543 | $117 |
| Diagnostic exam of bladder and urethra using an endoscope | 42 | $6,997 | $167 |
| Fitting and insertion of vaginal support device | 50 | $3,828 | $64 |
| Insertion of temporary bladder tube | 40 | $2,227 | $45 |
| Pessary, reusable, non rubber, any type | 48 | $2,198 | $43 |
| Short return visit | 55 | $1,918 | $33 |
| Automated urinalysis test | 203 | $987 | $3 |
| Ultrasound measurement of bladder capacity after voiding | 29 | $473 | $14 |
| Electronic assessment of bladder emptying | 15 | $200 | $12 |
2013: 15 services
| Short return visit (20+ min) | 359 | $31,054 | $59 |
| Return visit (30+ min) | 204 | $20,947 | $85 |
| Irrigation of vagina and/or application of drug to treat infection | 223 | $13,146 | $38 |
| New patient visit (45+ min) | 70 | $9,055 | $129 |
| Diagnostic exam of bladder and urethra using an endoscope | 43 | $7,165 | $167 |
| Fitting and insertion of vaginal support device | 45 | $3,530 | $67 |
| Insertion of lower leg neurostimulator electrode | 11 | $2,944 | $102 |
| Short return visit | 66 | $2,774 | $36 |
| Insertion of temporary bladder tube | 49 | $2,535 | $46 |
| Long return visit (40+ min) | 24 | $2,472 | $103 |
| Simple bladder irrigation and/or instillation | 11 | $2,103 | $70 |
| Pessary, reusable, non rubber, any type | 37 | $1,865 | $43 |
| Ultrasound measurement of bladder capacity after voiding | 45 | $899 | $16 |
| Automated urinalysis test | 182 | $857 | $3 |
| Electronic assessment of bladder emptying | 41 | $548 | $11 |
Medicaid work
$814 in 2024
Medicaid paid $814 for 1,076 billed services this clinician did in 2024, up to 46 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 162 | $350 |
| FETAL NON-STRESS TEST | 40 | $150 |
| Prenatal care, at-risk enhanced service; antepartum management | 292 | $150 |
| Return visit (30+ min) | 133 | $135 |
| Health behavior assessment | 23 | $15 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 174 | $15 |
| Subsequent prenatal care visit (Prenatal) [Excludes: patients who are seen for a condition unrelated to pregnancy or prenatal care (eg, an upper respiratory infection; patients seen for consultation only, not for continuing care)] | 82 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 65 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 31 | $0 |
| URINE PREGNANCY TEST | 27 | $0 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 13 | $0 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 18 | $0 |
| 2024 | 1,076 | 13 | 46 | $814 |
| 2023 | 2,855 | 22 | 93 | $6,286 |
| 2022 | 2,775 | 21 | 46 | $2,688 |
| 2021 | 194 | 5 | 26 | $0 |
See the largest Medicaid services in earlier years
2023
| OBSTETRICAL CARE | 26 | $2,014 |
| Prenatal care, at-risk enhanced service; antepartum management | 753 | $1,181 |
| Cesarean delivery | 24 | $826 |
| Short return visit (20+ min) | 228 | $592 |
| New patient visit (45+ min) | 44 | $586 |
| Return visit (30+ min) | 197 | $366 |
| FETAL NON-STRESS TEST | 144 | $294 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 30 | $120 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; non-automated, without microscopy | 392 | $70 |
| ANTEPARTUM CARE ONLY 4-6 VISITS | 16 | $60 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy | 283 | $52 |
| Screening for depression is documented as negative, a follow-up plan is not required | 40 | $50 |
2022
| Short return visit (20+ min) | 353 | $758 |
| Return visit (30+ min) | 291 | $530 |
| FETAL NON-STRESS TEST | 65 | $405 |
| Unclassified drugs | 27 | $373 |
| Cesarean delivery | 13 | $187 |
| New patient visit (45+ min) | 15 | $145 |
| Screening for depression is documented as negative, a follow-up plan is not required | 62 | $101 |
| URINE PREGNANCY TEST | 261 | $85 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 78 | $52 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 15 | $52 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $0 |
| Health behavior assessment | 222 | $0 |
2021
| Health behavior assessment | 30 | $0 |
| Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes | 25 | $0 |
| Preventive medicine counseling and risk factor reduction intervention for individual, approximately 15 minutes | 29 | $0 |
| Prenatal care, at-risk enhanced service; antepartum management | 95 | $0 |
| Prenatal care, at-risk enhanced service; education | 15 | $0 |
Drugs they prescribed that Part D paid
$15,618
Pharmacies billed $15,618 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 93) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
80 generic and 13 brand-name prescriptions · $15,618 in drug cost · 19 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 17 | $2,059 | $40 |
Year by year
| 2024 | 93 | 29 | 0% (0) | 14% | $15,618 |
| 2023 | 95 | 28 | 0% (0) | 16% | $11,835 |
| 2022 | 50 | 24 | 0% (0) | None | $4,245 |
| 2021 | 16 | None | None | None | $1,539 |
| 2018 | 84 | 20 | 0% (0) | 29% | $5,472 |
| 2017 | 97 | 28 | 0% (0) | 27% | $7,135 |
| 2016 | 71 | 25 | None | 49% | $11,138 |
| 2015 | 217 | 74 | None | 57% | $34,286 |
| 2014 | 401 | 131 | None | 42% | $46,605 |
| 2013 | 208 | 95 | None | None | $17,373 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Estradiol | 29 | $2,405 | $83 |
| Oxybutynin Chloride Er | 17 | $446 | $26 |
2022: 2 drugs
| Estradiol | 18 | $1,527 | $85 |
| Oxybutynin Chloride Er | 13 | $194 | $15 |
2018: 3 drugs
| Oxybutynin Chloride Er | 24 | $886 | $37 |
| Nitrofurantoin | 16 | $725 | $45 |
| Amitriptyline | 13 | $79 | $6 |
2017: 2 drugs
| Oxybutynin Chloride Er | 27 | $760 | $28 |
| Nitrofurantoin | 12 | $574 | $48 |
2016: 2 drugs
| Myrbetriq | 16 | $4,044 | $253 |
| Vesicare | 12 | $3,719 | $310 |
2015: 6 drugs
| Vesicare | 35 | $12,396 | $354 |
| Myrbetriq | 19 | $6,763 | $356 |
| Toviaz | 22 | $5,778 | $263 |
| Oxybutynin Chloride Er | 37 | $1,873 | $51 |
| Nitrofurantoin Mono-Macro | 11 | $304 | $28 |
| Sulfamethoxazole-Trimethoprim | 20 | $86 | $4 |
2014: 14 drugs
| Vesicare | 47 | $16,355 | $348 |
| Toviaz | 24 | $5,678 | $237 |
| Myrbetriq | 21 | $5,434 | $259 |
| Trospium Chloride Er | 23 | $3,964 | $172 |
| Premarin | 17 | $3,723 | $219 |
| Enablex | 12 | $2,556 | $213 |
| Estrace | 13 | $2,084 | $160 |
| Oxybutynin Chloride Er | 34 | $1,866 | $55 |
| Nitrofurantoin Mono-Macro | 44 | $1,301 | $30 |
| Nitrofurantoin | 26 | $1,046 | $40 |
| Oxybutynin Chloride | 11 | $286 | $26 |
| Sulfamethoxazole-Trimethoprim | 35 | $165 | $5 |
| Fluconazole | 18 | $84 | $5 |
| Ciprofloxacin | 12 | $79 | $7 |
2013: 6 drugs
| Toviaz | 11 | $2,530 | $230 |
| Trospium Chloride Er | 16 | $2,437 | $152 |
| Estrace | 16 | $2,262 | $141 |
| Oxybutynin Chloride Er | 24 | $1,511 | $63 |
| Nitrofurantoin | 31 | $1,499 | $48 |
| Nitrofurantoin Mono-Macro | 31 | $993 | $32 |
Money from drug and device companies
$10,590 in 2025
| 2025 | 5 | 14 | $6,695 | $10,590 |
| 2024 | 7 | 27 | $11,330 | $13,558 |
| 2023 | 4 | 20 | $13,135 | $14,696 |
| 2022 | 13 | 34 | None | $2,144 |
| 2021 | 2 | 3 | None | $99 |
| 2019 | 1 | 1 | None | $118 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Astellas Pharma US | Veozah | $10,492 | 9 payments
|
| Mayne Pharma Commercial | None | $35 | 2 payments
|
| Hologic Sales and Service | Aptima | $23 | 1 payment
|
| Ethicon US | Surgiflo Hemostatic Matrix | $21 | 1 payment
|
| Abbvie | Botox | $19 | 1 payment
|
See all 14 published payments
| Ethicon US | Meals · 2025-10-06 | Surgiflo Hemostatic Matrix | $21 |
| Abbvie | Meals · 2025-08-28 | Botox | $19 |
| Hologic Sales and Service | Meals · 2025-08-06 | Aptima | $23 |
| Astellas Pharma US | Meals · 2025-07-01 | Veozah | $9 |
| Astellas Pharma US | Travel · 2025-06-25 | Veozah | $2,029 |
| Astellas Pharma US | Paid to speak or teach · 2025-06-25 | Veozah | $3,090 |
| Astellas Pharma US | Meals · 2025-06-25 | Veozah | $122 |
| Mayne Pharma Commercial | Meals · 2025-05-29 | None | $20 |
| Mayne Pharma Commercial | Meals · 2025-04-23 | None | $15 |
| Astellas Pharma US | Meals · 2025-03-27 | Veozah | $139 |
| Astellas Pharma US | Travel · 2025-03-27 | Veozah | $1,477 |
| Astellas Pharma US | Paid to speak or teach · 2025-03-27 | Veozah | $3,090 |
| Astellas Pharma US | Paid to speak or teach · 2025-02-25 | Veozah | $515 |
| Astellas Pharma US | Meals · 2025-01-23 | Veozah | $22 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $13,558
| Astellas Pharma US | Veozah | $13,044 | 13 payments
|
| Coloplast | Altis | $215 | 2 payments
|
| Axonics | Axonics | $147 | 6 payments
|
| Hologic Sales and Service | Aptima | $53 | 2 payments
|
| Pfizer | Myfembree | $48 | 2 payments
|
| Abbvie | Botox | $27 | 1 payment
|
| Agile Therapeutics | Twirla | $24 | 1 payment
|
2023: $14,696
| Astellas Pharma US | Veozah | $14,461 | 12 payments
|
| Hologic Sales and Service | Acessa Provu System | $140 | 3 payments
|
| Axonics | Axonics | $63 | 3 payments
|
| Pfizer | Premarin | $32 | 2 payments
|
2022: $2,144
| Intuitive Surgical | Da Vinci Surgical System | $1,018 | 13 payments
|
| Coloplast | Altis | $474 | 7 payments
|
| Foundation Medicine | Foundationone Cdx | $229 | 1 payment
|
| Minerva Surgical | None | $153 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Opdivo | $96 | 1 payment
|
| TherapeuticsMD | Annovera | $38 | 2 payments
|
| Organon | Nexplanon | $24 | 2 payments
|
| Hologic | Acessa Provu System | $23 | 1 payment
|
| Boston Scientific | Solyx Sis System | $21 | 1 payment
|
| Pfizer | Premarin | $19 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Mirena | $19 | 1 payment
|
| Abbvie | Orilissa | $18 | 1 payment
|
| Axonics | Axonics | $12 | 1 payment
|
2021: $99
| Boston Scientific | Solyx | $70 | 1 payment
|
| Pfizer | Myfembree | $29 | 2 payments
|
2019: $118
| Hologic | Myosure | $118 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 72.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851530356
- Licence
- CT AS23832780684, IA DO-04672, IL 036218330
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207V00000X (207V00000X); Federal specialty code 207VG0400X (207VG0400X)
- Mailing address
- 1316 S Main St, Clarion, IA, 50525
- NPI first listed
- 2009-02-07
- NPI last updated
- 2026-08-17
- NPI record certified
- 2026-08-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1316 S Main St, Clarion, IA, 50525